Cart
sales@molnova.com
MK-4409
CAS No. 1207745-58-1
MK-4409( —— )
Catalog No. M34336 CAS No. 1207745-58-1
MK-4409 is a novel and selective inhibitor of oxazole fatty acid amide hydrolase FAAH.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 683 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1371 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2475 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMK-4409
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-4409 is a novel and selective inhibitor of oxazole fatty acid amide hydrolase FAAH.
-
DescriptionMK-4409 is a potent oxazole FAAH inhibitor and can be used for the research of inflammatory and neuropathic pain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFAAH
-
RecptorFAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1207745-58-1
-
Formula Weight441.91
-
Molecular FormulaC22H17ClFN3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC=1C=CC(=CC1)C2=NC(=C(O2)SC3=NC=C(Cl)C=C3)C=4C=NC(=CC4)C(O)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harry R Chobanian, et al. Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain. ACS Med Chem Lett. 2014 Apr 10;5(6):717-21.?
molnova catalog
related products
-
VU534
VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.
-
SSR 411298
SSR411298 is a highly selective, brain penetrant and orally-active inhibitor of FAAH with IC50 of 62.5 nM (mouse brain FAAH).
-
PDP-EA
PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
